6^th Annual Dementia Congress

Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most prevalent form of dementia, affecting millions worldwide and representing a major challenge for healthcare systems. It is characterized by progressive cognitive decline, memory impairment, and behavioral changes that significantly impact patients’ daily lives and the well-being of their caregivers. This topic will explore the most recent advances in understanding the pathophysiology of AD, including the formation and accumulation of amyloid-beta plaques, neurofibrillary tangles composed of tau proteins, and the role of neuroinflammation in accelerating neuronal loss. Emphasis will be placed on early detection methods, including biomarkers detectable in cerebrospinal fluid and blood, as well as innovative neuroimaging techniques that allow for the identification of disease processes before the onset of clinical symptoms. Participants will also examine emerging pharmacological interventions aimed at slowing disease progression, alongside non-pharmacological strategies such as cognitive stimulation, lifestyle interventions, and multidisciplinary approaches to patient care. Clinical trial outcomes, translational research, and real-world case studies will provide insights into the challenges and opportunities in managing Alzheimer’s Disease. Attendees will benefit from interactive discussions on ethical considerations, patient-centered care, and strategies for improving the quality of life for individuals living with AD. The topic encourages collaboration between neurologists, neuroscientists, clinicians, and researchers, highlighting how scientific discoveries are shaping the next generation of therapies and care models. By integrating clinical insights with research findings, participants will gain a comprehensive understanding of the disease and its impact on patients, families, and healthcare systems, preparing them to contribute meaningfully to advancements in dementia research and care.